The regulatory environment is exactly the same between the OTC (SEC filers) and Nasdaq CM.
The OTC and Nasdaq “rules” are different.
And you are correct that Nasdaq has a longer list of rules that need to be abided by in order to get listed and stay that OTC does not.
But the primary difference of late is that the OTC has become a lot harder to maintain quoted status and get financing. For example if an OTC stock is delinquent in its SEC filings it ends up on the Expert Market pretty quickly and loses solicited quotations.
On Nasdaq it does not. In fact Nasdaq gives companies an inordinate amount of time to cure the delinquency.
Same thing with Reverse splits. On the OTC where FINRA processes them they don’t just hand them out anymore like candy. Nasdaq on the other hand seems to not care at all…evidence MULN.
Until the buying demand, and I have no idea where it would come from, truly dries up…Michery will just keep diluting and selling stock to pay for his pretend EV company.
But that latest lawsuit is a doozy…and we may see more like it. Mullen has assets to go after.
Market Data 
Markets 
AI
